Boardroom Alpha
Start trial
10-Q primary document
QMCO · Quarterly Report (Form 10-Q) · Filed February 17, 2026

Quantum Corp — 10-Q exhibit

exhibit102-10xqfy26q3.htm
Quantum Corp on Boardroom Alpha
Document
Exhibit 10.2
AMENDMENT NO. 2
TO
QUANTUM CORPORATION
2021 INDUCEMENT PLAN
RECITALS
A.On February 1, 2021 the board of directors (the Board) of Quantum Corporation, a Delaware corporation (the Company) adopted the Quantum Corporation 2021 Inducement Plan (the Plan).
B.On December 30, 2022, the Leadership and Compensation Committee of the Board (the Committee) approved an amendment to the Plan to increase the number of shares of Common Stock of the Company authorized for issuance thereunder to 1,500,000 shares, pursuant to its authority under the Leadership and Compensation Committee Charter and Section 18(a) of the Plan.
C.On January 7, 2026 (the Effective Date), the Committee approved an amendment to the Plan to increase the number of shares of Common Stock of the Company authorized for issuance thereunder to 200,000 shares (reflective of the adjustment of the 1-share-for-20-shares reverse stock split executed in 2024), pursuant to its authority under the Leadership and Compensation Committee Charter and Section 18(a) of the Plan.
AMENDMENT
1.Section 3(a) of the Plan is hereby amended and restated as follows:
“Stock Subject to the Plan. Subject to the provisions of Section 13 of the Plan, the maximum aggregate number of Shares that may be issued under the Plan shall equal 200,000 Shares. The Shares may be authorized, but unissued, or reacquired Common Stock.”
2.Except as set forth in this amendment, the Plan shall be unaffected hereby and shall remain in full force and effect.
IN WITNESS WHEREOF, the Company has executed this Amendment No. 2 to the Quantum Corporation 2021 Inducement Plan on January 8, 2026.
QUANTUM CORPORATION
By:/s/ Tara Ilges
Tara Ilges
Vice President, Corporate Affairs and
Corporate Secretary

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer